BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7185381)

  • 1. [Hemodynamic and electrocardiographic effects of verapamil in ischemic cardiopathy].
    Aquaro G; Belli R; Ravera A; Rey L; Possavino G; Trucco G; Pavia M; Idone P
    Boll Soc Ital Cardiol; 1981; 26(12):2143-6. PubMed ID: 7185381
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effects of verapamil in patients with coronary insufficiency].
    Lamounier EN; Martinez EE; Herrmann JL; Guimarães RF; Martinez TL; Portugal OP
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():11-14. PubMed ID: 678161
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of ischemic heart disease with verapamil].
    Ostapiuk FE; Dobrotvorskaia TE; Khavazha KhA
    Sov Med; 1985; (11):78-81. PubMed ID: 4089643
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electrocardiographic and hemodynamic disorders induced by verapamil: experimental study].
    Belardinelli L; Sant'Anna JR; Mattos E; Wagner EM; Lucchese FA
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():31-6. PubMed ID: 329806
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of the acute hemodynamic effects of verapamil and nifedipine in patients with ischemic heart disease].
    Manfroi WC; Vieira SR; Ludwig RT; Goldim JR; Faraco EZ
    Arq Bras Cardiol; 1987 Feb; 48(2):123-8. PubMed ID: 3675228
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of isoptin on hemodynamics in patients with hypertension and ischemic heart disease].
    Zaslavskaia RM; Budenova LA; Vilkovyskiĭ FA; Malkin LM; Olevskiĭ IKh
    Klin Med (Mosk); 1985 Aug; 63(8):33-6. PubMed ID: 3908807
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of verapamil on echocardiographic dimensions of the left ventricle in ischemic cardiopathy: comparison with placebo, propranolol and trinitroglycerin].
    Fonzo R; Cherchi A; Bina P; Mercuro G; Lai C; Cioglia G; Sau F
    Boll Soc Ital Cardiol; 1979; 24(6):623-35. PubMed ID: 121796
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of verapamil on the acute experimental myocardial ischemia.
    Carp C; Pleşea O; Câmpeanu A
    Med Interne; 1980; 18(4):357-70. PubMed ID: 7455581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK; Zaĭtseva VI
    Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immediate effect of verapamil in hypertensive cardiopathy].
    Manfroi WC; Vieira SR; Ludwig R; Hemb R; de Azevedo DF; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1982 Dec; 39(6):417-20. PubMed ID: 6764615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-arrhythmic effectiveness of isoptin in ischemic heart disease in the middle-aged and elderly].
    Korkushko OV; Sarkisov KG; Butenko AG
    Vrach Delo; 1980 Jan; (1):30-5. PubMed ID: 7376578
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of finoptin on cerebrocardiac correlations in atherosclerotic circulatory encephalopathy in patients with ischemic heart disease].
    Dubenko OE; Ermakovich II
    Vrach Delo; 1988 Mar; (3):39-42. PubMed ID: 3394295
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effectiveness of treating patients with coronary insufficiency with verapamil].
    Kipsidze NN; Capidze GJ
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1284+. PubMed ID: 5536553
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of verapamil in coronariopathic patients. Evaluation using the ergometric test].
    Duarte GM; Ribeiro LG; Coelho W; Thevenard R; Souza PJ; Gonçalves MA; Carneiro RD; Luna RL
    Arq Bras Cardiol; 1976 Aug; 29(4):338-45. PubMed ID: 1008726
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of drugs upon exercise tests in coronary insuffiency.
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():79-81. PubMed ID: 329813
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of verapamil on the functional state of the liver in ischemic heart disease].
    Zharov EI; Makeeva LG; Svetova SD; Makarovskiĭ VV; Shafranskiĭ IuA; Vertkina NV
    Sov Med; 1991; (12):10-3. PubMed ID: 1780769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.